- Report
- February 2023
- 79 Pages
Asia Pacific
From €1432EUR$1,500USD£1,199GBP
- Report
- February 2023
- 72 Pages
North America
From €1432EUR$1,500USD£1,199GBP
- Report
- February 2023
- 79 Pages
Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- August 2022
Global
From €754EUR$790USD£632GBP
- Report
- July 2024
- 91 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2024
- 89 Pages
Global
From €3500EUR$3,929USD£3,035GBP
Onychomycosis is a fungal infection of the nail, which is a common condition affecting the toenails and fingernails. It is caused by a variety of fungi, including dermatophytes, yeasts, and molds. Treatment of onychomycosis is typically done with antifungal drugs, which are part of the infectious diseases drugs market. These drugs are used to treat a variety of fungal infections, including onychomycosis.
The onychomycosis drug market is composed of a variety of antifungal drugs, including topical and oral medications. Topical medications are applied directly to the affected nail, while oral medications are taken by mouth. These drugs are used to treat the infection and prevent it from spreading.
The onychomycosis drug market is highly competitive, with many companies offering a variety of antifungal drugs. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline. These companies offer a range of antifungal drugs, including topical and oral medications, to treat onychomycosis. Show Less Read more